Yael Hirsch-Moverman
Overview
Explore the profile of Yael Hirsch-Moverman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
719
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ratnayake A, Hernandez J, Justman J, Farley J, Hirsch-Moverman Y, Ho K, et al.
J Racial Ethn Health Disparities
. 2024 Sep;
PMID: 39264541
Background: Vaccine hesitancy has been a significant concern throughout the COVID-19 pandemic. Vaccine hesitancy can be attributed to lack of confidence in vaccines, complacency about the health threat, or lack...
2.
Hirsch-Moverman Y, Hsu A, Abrams E, Killam W, Moore B, Howard A
PLoS One
. 2024 Apr;
19(4):e0296993.
PMID: 38625930
Background: Tuberculosis (TB) preventive treatment (TPT) is recommended by the World Health Organization (WHO) for persons living with HIV, including pregnant and breastfeeding women. Given the President's Emergency Plan for...
3.
Justman J, Skalland T, Moore A, Amos C, Marzinke M, Zangeneh S, et al.
Emerg Infect Dis
. 2024 Jan;
30(2):245-254.
PMID: 38270128
During January-August 2021, the Community Prevalence of SARS-CoV-2 Study used time/location sampling to recruit a cross-sectional, population-based cohort to estimate SARS-CoV-2 seroprevalence and nasal swab sample PCR positivity across 15...
4.
Mugenyi L, Namuwenge P, Ouma S, Bakashaba B, Nanfuka M, Zech J, et al.
PLoS One
. 2024 Jan;
19(1):e0296239.
PMID: 38166009
Background: Tuberculosis (TB) remains the leading cause of death among people living with HIV (PLHIV). To prevent TB among PLHIV, the Ugandan national guidelines recommend Isoniazid Preventive Therapy (IPT) across...
5.
Mapingure M, Zech J, Hirsch-Moverman Y, Msukwa M, Howard A, Makoni T, et al.
J Int AIDS Soc
. 2023 Jun;
26(6):e26105.
PMID: 37339341
Introduction: Tuberculosis (TB) causes one-third of HIV-related deaths worldwide, making TB preventive treatment (TPT) a critical element of HIV programmes. Approximately 16% of people living with HIV (PLHIV) on antiretrovirals...
6.
Yuen C, Szkwarko D, Dubois M, Shahbaz S, Yuengling K, Urbanowski M, et al.
Bull World Health Organ
. 2022 Dec;
100(12):777-788L.
PMID: 36466210
Objective: To map which tuberculosis care models are best suited for children and adolescents. Methods: We conducted a scoping review to assess the impact of decentralized, integrated and family-centred care...
7.
Knox J, Kutner B, Shiau S, Winterhalter F, Wu Y, Hirsch-Moverman Y, et al.
AIDS Behav
. 2022 Jan;
26(7):2494-2502.
PMID: 35098392
The Information-Motivation-Behavioral Skills (IMB) Model has been used to understand adherence to medications and intentions to uptake pre-exposure prophylaxis (PrEP) to prevent HIV infection. In the current study, the IMB...
8.
Hirsch-Moverman Y, Strauss M, George G, Mutiti A, Mafukidze A, Shongwe S, et al.
BMJ Open
. 2021 Oct;
11(10):e048443.
PMID: 34686549
Objective: Isoniazid preventive therapy initiation and completion rates are suboptimal among children. Shorter tuberculosis (TB) preventive treatment (TPT) regimens have demonstrated safety and efficacy in children and may improve adherence...
9.
Hirsch-Moverman Y, Howard A, Mantell J, Lebelo L, Frederix K, Wills A, et al.
PLoS One
. 2021 May;
16(5):e0248516.
PMID: 34014956
Background: Child tuberculosis (TB) contact management is recommended for preventing TB in children but its implementation is suboptimal in high TB/HIV-burden settings. The PREVENT Study was a mixed-methods, clustered-randomized implementation...
10.
Wagman J, Wynn A, Matsuzaki M, Gnatienko N, Metsch L, Del Rio C, et al.
AIDS
. 2020 Oct;
34(15):2285-2294.
PMID: 33048870
Objectives: In high-income countries, hazardous alcohol use is associated with reduced receipt of antiretroviral therapy (ART) and viral suppression among people living with HIV (PLHIV) who inject drugs. These associations...